TELA - TELA Bio Inc

0.78
-0.062   -7.936%

Share volume: 65,818
Last Updated: 03-11-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$0.84
-0.06
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 33%
Dept financing 25%
Liquidity 75%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-11.87%
1 Month
-0.74%
3 Months
-32.17%
6 Months
-50.63%
1 Year
-65.64%
2 Year
-85.47%
Key data
Stock price
$0.78
P/E Ratio 
0.00
DAY RANGE
$0.76 - $0.84
EPS 
-$1.12
52 WEEK RANGE
$0.67 - $2.48
52 WEEK CHANGE
-$65.18
MARKET CAP 
59.028 M
YIELD 
N/A
SHARES OUTSTANDING 
40.342 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
-0.01
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$48,861
AVERAGE 30 VOLUME 
$69,689
Company detail
CEO: Antony Koblish
Region: US
Website: telabio.com
Employees: 120
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

TELA Bio, Inc. focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company markets its products through a single direct sales force, principally in the United States.

Recent news